City
Epaper

Nepal receives first batch of AstraZeneca vaccine from Japan

By ANI | Updated: August 8, 2021 11:25 IST

Nepal received the first batch of AstraZeneca COVID-19 vaccine from Japan on Saturday, local media reports said.

Open in App

Nepal received the first batch of AstraZeneca COVID-19 vaccine from Japan on Saturday, local media reports said.

Japan's envoy to Kathmandu Kikuta Yutaka handed over 05,13,420 vaccines to Nepal's Minister of Health and Population Umesh Shrestha at the country's Tribhuvan International Airport.

On Sunday evening, the vaccine's second batch will arrive in Kathmandu. The remaining half doses will be brought to the country soon, The Himalayan Times reported quoting Nepal's Foreign Affairs Ministry as saying.

Through the vaccine sharing scheme COVAX, Japan had promised to provide nearly 1.6 million doses of coronavirus vaccine to Kathmandu.

"Nepal appreciates Japan for their generous provision of life-saving vaccine to Nepal through COVAX. These Japanese-made AstraZeneca COVID vaccines will be administered to the senior citizens who are waiting for second shots of vaccines of this group," the country's foreign affairs ministry said in a press release on Saturday.

On Saturday, the country reported 2,231 new infections in the last 24 hours with the total number of cases reached to 7,12,740. Nepal has vaccinated nearly 68,02,415 people so far across the country.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: AstrazenecaAstrazeneca plc.Tribhuvan international airportAstrazeneca plcAstra zeneca
Open in App

Related Stories

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

International Realted Stories

InternationalPakistan scrambles to mitigate Trump tariffs, to send delegation to US

InternationalIndian Naval Officer pays courtesy visit to Maldives defence officials

InternationalIndia, France sign intergovernmental agreement on 26 Rafale Jets for Indian Navy

InternationalTrump wishes "good luck" to Canadians amid elections, proposes US statehood

InternationalPoland advances plan for first nuclear power plant